All Insiders Activity for Principia Biopharma Inc. (PRNB)

$ 100.05 0.00 (0.00%) Volume: 0 4:00 PM EDT Sep 25, 2020
Name: Transaction:
Date Name: Shares Transaction Value
09/18/20 Roy Hardiman,
Chief Business Officer
5,000 Sell at $99.9835 per share. $499,918
09/18/20 Roy Hardiman,
Chief Business Officer
2,242 Option Exercise at $7.2671 per share. $16,293
09/18/20 Roy Hardiman,
Chief Business Officer
2,758 Option Exercise at $4.7236 per share. $13,028
08/18/20 Dolca Thomas,
Chief Medical Officer
15,000 Option Exercise at $23.77 per share. $356,550
08/18/20 Christopher Y. Chai,
Chief Financial Officer
7,500 Option Exercise at $2.9977 per share. $22,483
08/18/20 Christopher Y. Chai,
Chief Financial Officer
7,500 Sell at $99.3653 per share. $745,240
08/18/20 Dolca Thomas,
Chief Medical Officer
15,000 Sell at $100.00 per share. $1,500,000
08/10/20 David M. Goldstein,
Chief Scientific Officer
2,534 Sell at $88.4026 per share. $224,012
08/10/20 David M. Goldstein,
Chief Scientific Officer
700 Sell at $89.6757 per share. $62,773
08/10/20 David M. Goldstein,
Chief Scientific Officer
700 Sell at $86.92 per share. $60,844
08/10/20 David M. Goldstein,
Chief Scientific Officer
100 Sell at $93.34 per share. $9,334
08/10/20 David M. Goldstein,
Chief Scientific Officer
1,108 Sell at $90.9891 per share. $100,816
08/10/20 David M. Goldstein,
Chief Scientific Officer
858 Sell at $86.1143 per share. $73,886
08/10/20 David M. Goldstein,
Chief Scientific Officer
3,553 Option Exercise at $3.1794 per share. $11,296
08/10/20 David M. Goldstein,
Chief Scientific Officer
2,447 Option Exercise at $2.9977 per share. $7,335
  Page 1 of 9   Next Page
View Section 16 Filings (Forms 3,4,5) for PRNB Insider Summary For PRNB